Erlotinib and rash Patient Reports February 11, 2012

Erlotinib Side Effects Report #5148762-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 15, 2006. Male patient, 47 years of age, weighting 183.9 lb, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood pressure diastolic increased, heart rate increased, odynophagia, rash , viral infection , white blood cell count decreased. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with AVASTIN, CISPLATIN, PRILOSEC, ZOFRAN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4954363-9
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 15, 2006. Male patient, 47 years of age, weighting 183.9 lb, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood pressure increased, rash , viral infection . Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with AVASTIN, CISPLATIN, PRILOSEC, ZOFRAN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5976474-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 14, 2008. Male patient, 78 years of age, weighting 189.6 lb, was diagnosed with renal cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood potassium decreased, blood urea increased, nausea , pneumonia , protein total decreased, rash , scleral hyperaemia, ventricular tachycardia. Erlotinib dosage: (125 MG,QD), ORAL. During the same period patient was treated with ASPIRIN, LIPITOR, LASIX, POTASSIUM CHLORIDE, PLAVIX, TOPROL, FOLIC ACID. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5691943-X
Erlotinib side effect was reported by a Physician from JAPAN on Feb 11, 2008. Female patient, 57 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, gastritis, intestinal obstruction, oral intake reduced, rash . Erlotinib dosage: 100 MG QD ORAL. During the same period patient was treated with GEMCITABINE, OXYCODOONE, MORPHINE, OMEPRAZOLE, SUCRALFATE, LOXOPROFEN, ITOPRIDE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5705284-5
Erlotinib side effect was reported by a Physician from JAPAN on Mar 26, 2008. Male patient, 50 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gastritis, intestinal obstruction, oral intake reduced, peritoneal disorder, peritoneal neoplasm, rash . Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with GEMCITABINE, OXYCODONE, MORPHINE, OMEPRAZOLE, SUCRALFATE, LOXOPROFEN, ITOPRIDE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5688183-7
Erlotinib side effect was reported by a Physician from ROMANIA on Mar 14, 2008. Male patient, 58 years of age, was diagnosed with non-small cell lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, cardio-respiratory arrest, gamma-glutamyltransferase increased, rash , white blood cell count increased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with CARBOPLATIN, ETOPOSIDE, DOCETAXEL. Patient died on 11/10/2007.

Erlotinib Side Effects Report #4599677-X
Erlotinib side effect was reported by a Health Professional from on Mar 04, 2005. Female patient, 87 years of age, weighting 139.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: hypersensitivity, rash . Erlotinib dosage: 150 MG PO QD. During the same period patient was treated with CARDIZEM, VITAMIN SUPPLEMENTS, PRILOSEC, COLACE. Patient recovered.

Erlotinib Side Effects Report #5691881-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 01, 2008. Male patient, 84 years of age, weighting 141.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain upper, anaemia, anorexia, back pain , constipation , failure to thrive, malignant neoplasm progression, rash , weight decreased. Erlotinib dosage: 150 MG DAILY 047 PO. During the same period patient was treated with BEVACIZUMAB, HYTRIN, ZOCOR, NEURONTIN, GEMFIBROZIL, NORTRIPTYLINE, GLYBURIDE AND METFORMIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5744908-3
Erlotinib side effect was reported by a Health Professional from JAPAN on May 02, 2008. Female patient, 78 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: delirium, dementia , disease progression, disorientation, memory impairment, rash . Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with WARFARIN POTASSIUM, ALFACALCIDOL, RISEDRONIC ACID, ASPARA, LACTOBACILLUS BIFIDUS, OMEPRAL, ETODOLAC, OXYCONTIN. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5386371-0
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on June 25, 2007. Female patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, oral intake reduced, rash . Erlotinib dosage: unknown. Patient died.

Erlotinib Side Effects Report #5501142-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 11, 2007. Male patient, 74 years of age, weighting 124.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: mouth haemorrhage, rash . Erlotinib dosage: (150 MG,QD),ORAL; (100 MG,QD), ORAL. During the same period patient was treated with VELCADE, NORTRIPTYLINE, INDOCIN, TETRACYCLINE. Patient died.

Erlotinib Side Effects Report #5856708-4
Erlotinib side effect was reported by a Physician from JAPAN on Aug 05, 2008. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: paronychia, rash . Erlotinib dosage: (100 MG,QD), ORAL. Patient recovered.

Erlotinib Side Effects Report #5897649-6
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 08, 2008. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, hypoglycaemia, rash . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with GLYBURIDE, ADALAT, GLUCOBAY, INDERAL, OLMETEC, LIPITOR, ROHYPNOL, DEPAS. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5918087-3
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 26, 2008. Female patient, 74 years of age, weighting 123.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activities of daily living impaired, blood pressure decreased, diarrhoea, feeling abnormal, loss of consciousness, paronychia, rash . Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AMLODIPINE BESYLATE, OLMETEC. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #6022310-7
Erlotinib side effect was reported by a Physician from JAPAN on Dec 10, 2008. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: hypoglycaemia, rash . Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with GLYBURIDE, ADALAT, GLUCOBAY, INDERAL, OLMETEC, LIPITOR, ROHYPNOL, DEPAS. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5900835-X
Erlotinib side effect was reported by a Physician from ROMANIA on Sept 11, 2008. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: rash . Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with NAVELBINE, TAXOTERE. Patient died.

Erlotinib Side Effects Report #5169333-8
Erlotinib side effect was reported by a Physician from GERMANY on Nov 15, 2006. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: oedema peripheral, pain , rash , skin necrosis, ulcer . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with FUROSEMIDE, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4738431-2
Erlotinib side effect was reported by a Physician from PERU on July 22, 2005. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypovolaemic shock, multi-organ failure, rash . Erlotinib dosage: 150 MG (QD) ORAL. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 04/22/2005.

Erlotinib Side Effects Report #5012296-6
Erlotinib side effect was reported by a Physician from PERU on May 10, 2006. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypovolaemic shock, multi-organ failure, rash . Erlotinib dosage: unknown. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 04/22/2005.


Erlotinib Side Effects Report #5034583-8
Erlotinib side effect was reported by a Physician from PERU on May 23, 2006. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypovolaemic shock, multi-organ failure, performance status decreased, rash . Erlotinib dosage: 150 MG 1 X PER DAY / ORAL. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient died.

Erlotinib Side Effects Report #5034654-6
Erlotinib side effect was reported by a Physician from PERU on June 05, 2006. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypovolaemic shock, multi-organ failure, performance status decreased, rash . Erlotinib dosage: unknown. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 04/22/2005.

Erlotinib Side Effects Report #5856816-8
Erlotinib side effect was reported by a Physician from JAPAN on Aug 08, 2008. Male patient, 70 years of age, weighting 120.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac tamponade, cholecystitis, hepatic function abnormal, rash . Erlotinib dosage: (150 MG, QD) ,ORAL. Patient recovered.

Erlotinib Side Effects Report #5869361-0
Erlotinib side effect was reported by a Health Professional from JAPAN on Aug 08, 2008. Male patient, 70 years of age, weighting 120.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac tamponade, hepatic function abnormal, interstitial lung disease, rash . Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with TAZOCIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4544972-3
Erlotinib side effect was reported by a Consumer or non-health professional from on Dec 20, 2004. Female patient, 69 years of age, weighting 175.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: eye pruritus, ocular hyperaemia, rash , skin discolouration. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with LATANOPROST, DIPIVEFRINE. Patient recovered.


Erlotinib Side Effects Report #4544984-X
Erlotinib side effect was reported by a Physician from on Dec 14, 2004. Female patient, 69 years of age, weighting 175.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, disorientation, erythema, prothrombin time prolonged, pruritus, rash , skin discolouration. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with PROPINE EYE DROPS, XALATAN EYE GTTS. Patient recovered.

Erlotinib Side Effects Report #6120798-4
Erlotinib side effect was reported by a Physician from BRAZIL on Feb 26, 2009. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, hypertension, rash , skin infection. Erlotinib dosage: 150 MG (150 MG,QD), ORAL. During the same period patient was treated with OMEPRAZOLE, DEXAMETHASONE, NYSTATIN, METOCLOPRAMIDE, MORPHINE. Patient was hospitalized. Patient died on 07/12/2005.

Erlotinib Side Effects Report #5954650-1
Erlotinib side effect was reported by a Health Professional from UNITED KINGDOM on Oct 29, 2008. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac failure, cardiac failure congestive, cardiomegaly, pneumonia , rash , stomatitis. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with ASPIRIN, AMLODIPINE, LACTULOSE. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #6088054-0
Erlotinib side effect was reported by a Physician from JAPAN on Feb 05, 2009. Female patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: rash . Erlotinib dosage: (150 MG, QD,), ORAL. Patient died on 12/15/2008.

Erlotinib Side Effects Report #4781644-4
Erlotinib side effect was reported by a Physician from GERMANY on Sept 12, 2005. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, malignant neoplasm progression, metastases to lung, non-small cell lung cancer, rash , vision blurred, visual disturbance. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with SPIRONOLACTONE, FUROSEMIDE, ACETYLCYSTEINE, ASPIRIN, PREDNISONE, ALBUTEROL SULPHATE, ZOMETA. Patient was hospitalized and became disabled. Patient recovered.


Erlotinib Side Effects Report #5828472-6
Erlotinib side effect was reported by a Physician from JAPAN on July 14, 2008. Female patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bone marrow failure, dyspnoea, rash , thrombocytopenia. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with LOXONIN, SELBEX, GASTER D, LENDORM, MAGNESIUM OXIDE, AMLODIPINE BESYLATE, OXYCODONE, LIPITOR. Patient recovered.

Erlotinib Side Effects Report #5890308-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 03, 2008. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: benign prostatic hyperplasia, cataract , optic neuropathy, rash . Erlotinib dosage: unknown. During the same period patient was treated with LIPITOR, LOTREL, MOTRIN, VICODIN, GLUCOSAMINE, CHONDROITIN SULPHATE, DYAZIDE, PROTONIX. Patient recovered.

Erlotinib Side Effects Report #5981842-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 17, 2008. Male patient, 65 years of age, weighting 224.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: benign prostatic hyperplasia, cataract , glaucoma , impaired driving ability, optic atrophy, optic neuropathy, rash , vision blurred. Erlotinib dosage: unknown. During the same period patient was treated with BEVACUZUMAB, CARBOPLATIN, TAXOL, LIPITOR, LOTREL, MOTRIN, VICODIN, GLUCOSAMINE. Patient recovered.

Erlotinib Side Effects Report #4901777-9
Erlotinib side effect was reported by a Pharmacist from UNITED STATES on Feb 01, 2006. Female patient, 62 years of age, weighting 74.50 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, dyspnoea, hyperhidrosis, pruritus, pyrexia, rash . Erlotinib dosage: 150MG DAILY PO. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5755635-0
Erlotinib side effect was reported by a Physician from JAPAN on May 12, 2008. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase decreased, c-reactive protein increased, laboratory test abnormal, rash . Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MAXIPIME, CIPROFLOXACIN, MEROPEN. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5818452-9
Erlotinib side effect was reported by a Physician from JAPAN on July 03, 2008. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase decreased, interstitial lung disease, laboratory test abnormal, rash . Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MAXIPIME, CIPROFLOXACIN, MEROPEN, MUCODYNE, MAGLAX, NOVAMIN, NAIXAN, OXYCONTIN. Patient was hospitalized. Patient died on 04/30/2008.

Erlotinib Side Effects Report #5203381-4
Erlotinib side effect was reported by a Physician from HONG KONG on Dec 22, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: escherichia urinary tract infection, lung neoplasm malignant, rash , urinary tract infection enterococcal. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died on 12/27/2005.

Erlotinib Side Effects Report #6137759-1
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 11, 2009. Male patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: body temperature decreased, dehydration, diarrhoea, fatigue, hypomagnesaemia, rash , renal failure acute, renal impairment, thirst. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4663266-9
Erlotinib side effect was reported by a Physician from on Apr 29, 2005. Male patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypovolaemic shock, multi-organ disorder, rash . Erlotinib dosage: unknown. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 04/23/2005.

Erlotinib Side Effects Report #5477789-6
Erlotinib side effect was reported by a Physician from ARGENTINA on Sept 17, 2007. Male patient, 67 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: rash . Erlotinib dosage: (150 MG, QD), ORAL. Patient died.


Erlotinib Side Effects Report #5811361-0
Erlotinib side effect was reported by a Health Professional from JAPAN on June 26, 2008. Female patient, 66 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, rash , thrombocytopenia. Erlotinib dosage: unknown. During the same period patient was treated with LOXONIN, SELBEX, FAMOTIDINE, LENDORM, MAGNESIUM OXIDE, AMLODIPINE BESYLATE, OXYCODONE, LIPITOR. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5088887-3
Erlotinib side effect was reported by a Pharmacist from UNITED STATES on Aug 24, 2006. Male patient, 61 years of age, weighting 126.0 lb, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: rash . Erlotinib dosage: 15MG DAILY ORAL. During the same period patient was treated with NEUPOGEN, GABAPENTIN, TEMAZEPAM. Patient recovered.

Erlotinib Side Effects Report #5822588-6
Erlotinib side effect was reported by a Physician from JAPAN on July 11, 2008. Male patient, 79 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood pressure decreased, interstitial lung disease, pyrexia, rash . Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5897654-X
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 08, 2008. Male patient, 79 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood pressure decreased, interstitial lung disease, pyrexia, rash . Erlotinib dosage: (150 MG,QD), ORAL. Patient was hospitalized. Patient died on 07/05/2008.

Erlotinib Side Effects Report #6093031-X
Erlotinib side effect was reported by a Physician from JAPAN on Feb 10, 2009. Male patient, 79 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, lung adenocarcinoma, malignant neoplasm progression, rash . Erlotinib dosage: 150 MG QD; ORAL. During the same period patient was treated with GASTER D, MAGMITT, BEZATOL. Patient died on 01/27/2009.

Erlotinib Side Effects Report #5776197-8
Erlotinib side effect was reported by a Physician from JAPAN on May 30, 2008. Female patient, 77 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, eye disorder, hepatic function abnormal, ingrowing nail, rash , stomatitis. Erlotinib dosage: (100 MG,GD),ORAL. During the same period patient was treated with PRAVASTATIN, NAUZELIN, MUCOSTA, ZOLPIDEM TARTRATE, AMOBAN. Patient recovered.

Erlotinib Side Effects Report #5776197-8
Erlotinib side effect was reported by a Physician from JAPAN on May 30, 2008. Female patient, 77 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, eye disorder, hepatic function abnormal, ingrowing nail, rash , stomatitis. Erlotinib dosage: (100 MG,GD),ORAL. During the same period patient was treated with PRAVASTATIN, NAUZELIN, MUCOSTA, ZOLPIDEM TARTRATE, AMOBAN. Patient recovered.

Erlotinib Side Effects Report #6125546-X
Erlotinib side effect was reported by a Physician from JAPAN on Mar 03, 2009. Female patient, 77 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, hepatic function abnormal, hyperlipidaemia, ingrowing nail, insomnia, keratitis, osteoporosis , rash , stomatitis. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with PRAVASTATIN, NAUZELIN, MUCOSTA, AMOBAN, ZOLPIDEM TARTRATE. Patient recovered.

Erlotinib Side Effects Report #5765517-6
Erlotinib side effect was reported by a Physician from JAPAN on May 19, 2008. Female patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: paronychia, rash , stomatitis. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with NORVASC. Patient recovered.

Erlotinib Side Effects Report #6016641-4
Erlotinib side effect was reported by a Physician from JAPAN on Dec 05, 2008. Female patient, 75 years of age, weighting 123.5 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, keratitis, paronychia, rash , stomatitis. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with NORVASC. Patient recovered.


Erlotinib Side Effects Report #6099808-9
Erlotinib side effect was reported by a Physician from JAPAN on Feb 13, 2009. Female patient, 75 years of age, weighting 143.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, arterial thrombosis limb, diarrhoea, disease progression, nausea , rash . Erlotinib dosage: (150 MG, QD), ORAL; (150 MG, QD), ORAL. During the same period patient was treated with VITAMEDIN, METHYCOBAL, PRAVASTATIN, LOXONIN, SELBEX, NAUZELIN. Patient recovered.

Erlotinib Side Effects Report #5889278-5
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 02, 2008. Male patient, 73 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pyrexia, rash , white blood cell count increased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with METHYCOBAL, PREDONINE, ALTAT, MOBIC, SENNOSIDES, ALESION, MOHRUS. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6128091-0
Erlotinib side effect was reported by a Physician from JAPAN on Mar 05, 2009. Female patient, 72 years of age, weighting 121.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, pyrexia, rash . Erlotinib dosage: 150 MG, QD, ORAL; 100 MG, QD, ORAL. During the same period patient was treated with CANDESARTAN CILEXETIL, NEUROTROPIN, TIZANIDINE, MESITAT, MICODYNE, TAGAMET, APLACE. Patient recovered.

Erlotinib Side Effects Report #5828474-X
Erlotinib side effect was reported by a Physician from JAPAN on July 14, 2008. Female patient, 70 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, rash , skin ulcer. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with DIART, CELECOXIB, TIZANIDINE, MUCOSTA, HUSTAZOL, ALDACTONE, PREDNISONE, BROCIN. Patient recovered.

Erlotinib Side Effects Report #5935297-X
Erlotinib side effect was reported by a Physician from JAPAN on Oct 13, 2008. Female patient, 70 years of age, weighting 77.16 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, rash . Erlotinib dosage: (150 MG, QD), ORAL. Patient recovered.

Erlotinib Side Effects Report #6025190-9
Erlotinib side effect was reported by a Physician from JAPAN on Dec 15, 2008. Female patient, 70 years of age, weighting 122.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, malignant neoplasm progression, pain , pruritus, rash , skin ulcer. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DIART, CELECOXIB, TIZANIDINE, MUCOSTA, HUSTAZOL, ALDACTONE, PREDNISOLONE, BROCIN. Patient died on 07/24/2008.

Erlotinib Side Effects Report #6106850-8
Erlotinib side effect was reported by a Physician from JAPAN on Feb 17, 2009. Female patient, 70 years of age, weighting 122.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, malignant neoplasm progression, pain , pruritus, rash , skin ulcer. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with DIART, CELECOXIB, TIZANIDINE, MUCOSTA, HUSTAZOL, ALDACTONE, PREDNISOLONE, BROCIN. Patient died on 07/24/2008.

Erlotinib Side Effects Report #5788681-1
Erlotinib side effect was reported by a Physician from JAPAN on June 09, 2008. Male patient, 69 years of age, was diagnosed with lung adenocarcinoma, pyrexia and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disease progression, dyspnoea, pruritus, pyrexia, rash , rhinorrhoea. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with FINIBAX, ADALAT, MUCODYNE, HOKUNALIN, THEOLONG, PREDONINE. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5818453-0
Erlotinib side effect was reported by a Physician from JAPAN on July 03, 2008. Male patient, 69 years of age, was diagnosed with lung adenocarcinoma, pyrexia and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disease progression, dyspnoea, pruritus, pyrexia, rash , rhinorrhoea. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with FINIBAX, ADALAT, MUCODYNE, HOKUNALIN, THEOLONG, PREDONINE. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5913781-2
Erlotinib side effect was reported by a Physician from JAPAN on Sept 22, 2008. Female patient, 68 years of age, weighting 130.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: henoch-schonlein purpura, hyperbilirubinaemia, paronychia, rash . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LENDORM, ALOSENN, MAGNESIUM OXIDE, DIOVAN, LOXONIN, RHYTHMY, GASTER D, ACTONEL. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5936212-5
Erlotinib side effect was reported by a Health Professional from JAPAN on Oct 13, 2008. Female patient, 68 years of age, weighting 130.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: henoch-schonlein purpura, hyperbilirubinaemia, paronychia, pneumonia , rash . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LENODORMIN, ALOSENN, MAGNESIUM OXIDE, DIOVAN, LOXONIN, RHYTHMY, GASTER D, ACTONEL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5839447-5
Erlotinib side effect was reported by a Physician from JAPAN on July 25, 2008. Male patient, 67 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, malignant neoplasm progression, pneumonia klebsiella, rash . Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with MEDICON, BIOFERMIN, GOODMIN, ADONA, MUCOSOLVAN, ALLELOCK. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5856881-8
Erlotinib side effect was reported by a Physician from JAPAN on Aug 07, 2008. Female patient, 67 years of age, weighting 80.25 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, malaise, rash . Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with ZANTAC, MUCOSTA, LOXONIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5900778-1
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 12, 2008. Male patient, 67 years of age, weighting 132.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, dizziness , eye disorder, infection , paraesthesia oral, pyrexia, rash . Erlotinib dosage: (150 MG, QD), ORAL; (100 MG, QD), ORAL. During the same period patient was treated with MAGLAX, LASIX, ACECOL, ASPIRIN, IRESSA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6088069-2
Erlotinib side effect was reported by a Physician from JAPAN on Feb 06, 2009. Female patient, 64 years of age, weighting 121.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, disease progression, gastritis, haemorrhage, haemothorax, rash , urinary tract infection . Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with GASTER D, TOCOPHEROL CONCENTRATE CAP, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5832839-X
Erlotinib side effect was reported by a Health Professional from JAPAN on July 18, 2008. Female patient, 63 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: paronychia, rash . Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with HACHIAZULE, CEFDINIR. Patient recovered.

Erlotinib Side Effects Report #5935299-3
Erlotinib side effect was reported by a Physician from JAPAN on Oct 13, 2008. Male patient, 62 years of age, weighting 138.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: delirium, depression , diarrhoea, disease progression, hepatic function abnormal, interstitial lung disease, lung adenocarcinoma, rash , restlessness. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MYSLEE, DEPAKENE, GASMOTIN, METHYCOBAL, CYTOTEC, OXYCONTIN, NAIXAN, GASTROM. Patient died.

Erlotinib Side Effects Report #6025539-7
Erlotinib side effect was reported by a Physician from JAPAN on Dec 15, 2008. Male patient, 62 years of age, weighting 138.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: delirium, depression , diarrhoea, hepatic function abnormal, interstitial lung disease, lung adenocarcinoma, malignant neoplasm progression, rash , restlessness. Erlotinib dosage: 150 MG, QD; ORAL. During the same period patient was treated with MYSLEE, DEPAKENE, GASMOTIN, METHYCOBAL, CYTOTEC, OXYCONTIN, NAIXAN, GASTROM. Patient died on 07/02/2008.

Erlotinib Side Effects Report #6052263-7
Erlotinib side effect was reported by a Physician from JAPAN on Jan 05, 2009. Male patient, 62 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: lung adenocarcinoma, malignant neoplasm progression, metastases to liver, metastases to peritoneum, peritonitis, rash . Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with MORPHINE, DICLOFENAC, REBAMIPIDE, DIAZEPAM. Patient died on 06/06/2008.

Erlotinib Side Effects Report #5839446-3
Erlotinib side effect was reported by a Physician from JAPAN on Apr 22, 2008. Female patient, 61 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, haemoptysis, metastases to bone, rash , tumour haemorrhage. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with ROPION, MAGNESIUM OXIDE, MORPHINE, MAXIPIME, MIDAZOLAM, CEFIPIME. Patient died on 03/31/2008.


Erlotinib Side Effects Report #6051349-0
Erlotinib side effect was reported by a Physician from JAPAN on Jan 05, 2009. Male patient, 61 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, rash . Erlotinib dosage: unknown. Patient recovered.

Erlotinib Side Effects Report #5722246-2
Erlotinib side effect was reported by a Physician from JAPAN on Apr 11, 2008. Female patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, hyponatraemia, malignant neoplasm progression, oedema, rash , white blood cell count increased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with OMEPRA, DEPAS, NORVASC, ZOLPIDEM TARTRATE. Patient died on 03/31/2008.

Erlotinib Side Effects Report #5930349-2
Erlotinib side effect was reported by a Physician from JAPAN on Oct 10, 2008. Male patient, 57 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pneumothorax, rash . Erlotinib dosage: (150 MG, QD) ,ORAL; (100 MG, QD) ,ORAL; (75 MG, QD) ,ORAL. During the same period patient was treated with BISOLVON, MUCOSAL, MOBIC, FAMOTIDINE, CODEINE PHOSPHATE, MUCOSTA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5817461-3
Erlotinib side effect was reported by a Physician from JAPAN on June 30, 2008. Female patient, 56 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, duodenal ulcer, rash . Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with GASTER D, LOXONIN, MAGLAX. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5913975-6
Erlotinib side effect was reported by a Physician from JAPAN on Sept 22, 2008. Male patient, 56 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: constipation , lymphocyte count decreased, rash , rectal ulcer haemorrhage. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with GLYCEROL, ZOLPIDEM TARTRATE, PURSENNID, OXYCONTIN, NOVAMIN, ALUMINUM HYDROXIDE, MUCOSTA, DEPAS. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5963876-2
Erlotinib side effect was reported by a Physician from JAPAN on Nov 05, 2008. Male patient, 56 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: lymphocyte count decreased, pyrexia, rash , rectal ulcer haemorrhage. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with GLYCEROL, LANSOPRAZOLE, ZOLPIDEM TARTRATE, PURSENNID, OXYCONTIN, NOVAMIN, ALUMINUM HYDROXIDE, MUCOSTA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6051350-7
Erlotinib side effect was reported by a Physician from JAPAN on Jan 05, 2009. Female patient, 56 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood bilirubin increased, duodenal ulcer, lung adenocarcinoma, malignant neoplasm progression, rash . Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with LOXONIN, GASTER D, MAGLAX. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5862217-9
Erlotinib side effect was reported by a Physician from JAPAN on Aug 12, 2008. Male patient, 53 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchostenosis, cardio-respiratory arrest, disease progression, dyspnoea, haemoptysis, hepatic function abnormal, rash , shock, white blood cell count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MEDICON, MUCOSOLVAN, MUCODYNE, ZOLPIDEM TARTRATE, LOXONIN, HUSTAGIN, APRICOT, CODEINE PHOSPHATE. Patient died on 07/26/2008.

Erlotinib Side Effects Report #6128094-6
Erlotinib side effect was reported by a Physician from JAPAN on Mar 05, 2009. Female patient, 53 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ingrowing nail, platelet count decreased, rash . Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DEPAKENE, GLYCEOL, BETAMETHASONE, PURSENNID, MUCOSTA. Patient recovered.

Erlotinib Side Effects Report #5794863-5
Erlotinib side effect was reported by a Health Professional from JAPAN on June 11, 2008. Female patient, 42 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, hypoxia, interstitial lung disease, rash . Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with DEPAKENE, BETAMETHASONE. Patient died.


Erlotinib Side Effects Report #5918088-5
Erlotinib side effect was reported by a Physician from HONG KONG on Sept 26, 2008. Female patient, 40 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gingival bleeding, haematemesis, haematoma, haemorrhage, petechiae, rash , thrombocytopenia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, INNOHEP. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5203400-5
Erlotinib side effect was reported by a Health Professional from CANADA on Dec 20, 2006. Female patient, 50 years of age, was diagnosed with colorectal cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood bilirubin increased, intestinal obstruction, rash , small intestinal obstruction. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with CAPECITABINE, LOPERAMIDE, MAGNESIUM HYDROXIDE, COLACE, POTASSIUM CHLORIDE, METHYLPHENIDATE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4815154-2
Erlotinib side effect was reported by a Health Professional from SINGAPORE on Oct 10, 2005. Male patient, 46 years of age, was diagnosed with bronchial neoplasm, lung neoplasm and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, condition aggravated, lung infiltration, mediastinal disorder, pleural effusion, pleuritic pain, pyrexia, rash . Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5913974-4
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 22, 2008. Female patient, 77 years of age, weighting 115.7 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aplastic anaemia, rash . Erlotinib dosage: (150 MG, QD), ORAL, (50 MG,QD), ORAL. During the same period patient was treated with NEORAL, NEUQUINON, BACTRIM, LASIX. Patient recovered.

Erlotinib Side Effects Report #6108684-7
Erlotinib side effect was reported by a Physician from JAPAN on Feb 20, 2009. Female patient, 77 years of age, weighting 115.7 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: neutrophil count decreased, platelet count decreased, rash . Erlotinib dosage: (150 MG, QD), ORAL : (50 MG, QD), ORAL. During the same period patient was treated with NEORAL, NEUQUINON, BACTRIM, LASIX. Patient recovered.

Erlotinib Side Effects Report #5168696-7
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2006. Male patient, 75 years of age, weighting 151.0 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: rash . Erlotinib dosage: unknown. Patient recovered.

Erlotinib Side Effects Report #6120265-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 25, 2009. Female patient, 72 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: conjunctivitis, dehydration, fungal infection , hypophagia, impetigo , mucosal inflammation, rash , skin exfoliation, staphylococcal infection . Erlotinib dosage: 1150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6081651-8
Erlotinib side effect was reported by a Health Professional from JAPAN on Jan 30, 2009. Female patient, 53 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ingrowing nail, platelet count decreased, rash . Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DEPAKENE, GLYCEOL, BETAMETHASONE, PURSENNID, MUCOSTA. Patient recovered.

Erlotinib Side Effects Report #4697727-3
Erlotinib side effect was reported by a Pharmacist from on June 21, 2005. Male patient, 49 years of age, weighting 196.9 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, rash . Erlotinib dosage: unknown. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5932680-3
Erlotinib side effect was reported by a Physician from JAPAN on Oct 09, 2008. Male patient, 26 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, nausea , pyrexia, rash . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with OXYCONTIN, NOVAMIN, MORPHINE, MAGMITT, PURSENNID, LOXONIN, MUCOSTA. Patient was hospitalized. Patient recovered.